METHYL 5-(3-((1S)-1-(2-HYDROXYETHYLAMINO)-2,3-DIHYDRO-1H-INDEN-4-YL)-1,2,4-OXADIAZOL-5-YL)-2-PROPAN-2-YLOXYBENZOATE
UNII NC6YW7Y49H
Substance Identification & Data
This profile provides standardized clinical and technical data for Methyl 5-(3-((1s)-1-(2-hydroxyethylamino)-2,3-dihydro-1h-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-propan-2-yloxybenzoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NC6YW7Y49H.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2918298-57-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H27N3O5 GHANPPUFCJJUFP-FQEVSTJZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Methyl 5-(3-((1s)-1-(2-hydroxyethylamino)-2,3-dihydro-1h-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-propan-2-yloxybenzoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.